Foreign Affairs

200% Trump tariff shock? India’s cheap pills may still beat US rivals

· 22 July 2026 · 2 min read
200% Trump tariff shock? India’s cheap pills may still beat US rivals

The Economic Times has reported a new India-focused foreign affairs development: “200% Trump tariff shock? India’s cheap pills may still beat US rivals.” The publisher's feed describes the story as follows: US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical exporters, but the country's cost advantage may help many drugs remain competitive in the US market, according to the Global Trade Research Initiative (GTRI).

Original reporting by The Economic TimesRead the full story

Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.

#foreign-affairs#india

Related reading

IJP
News Brief
Foreign secretary Vikram Misri flags tariff move in talks with US undersecretary
Foreign Affairs·The Economic Times·25 Sep 2026

Foreign secretary Vikram Misri flags tariff move in talks with US undersecretary

Read full story →
IJP
News Brief
India and the plausible multilateralism of BRICS
Foreign Affairs·The Hindu·25 Sep 2026

India and the plausible multilateralism of BRICS

Read full story →
IJP
News Brief
CEA flags US friction, energy shocks, and missing AI play as India’s key near-term risks
Foreign Affairs·Mint·25 Sep 2026

CEA flags US friction, energy shocks, and missing AI play as India’s key near-term risks

Read full story →
IJP
News Brief
India, 17 others reserve rights to join Russia’s CBAM dispute with EU as third party at WTO
Foreign Affairs·The Economic Times·25 Sep 2026

India, 17 others reserve rights to join Russia’s CBAM dispute with EU as third party at WTO

Read full story →